Jack Hutter DPM, C.ped, FACFAS, FAPWCA, Diplomate, ABPFAS

Jack Hutter DPM, C.ped, FACFAS, FAPWCA,
Diplomate, ABPFAS




Laser therapies
Chemical treatment of verruca plantaris
Minimally invasive surgical of heel pain caused
by plantar fascitis
Treatment of plantar fibromatosis


Laser antimicrobial therapy
Multiwave Locked System laser
Light Amplification by Stimulated Emission of
Radiation







UV- C 100 – 280 nm
UV- B 280 – 315 nm
UV- A 315 – 400 nm
VIS 400 – 560 nm
IR – A 560 – 1400 nm
IR- B 1400 – 3000 nm
IR- C 3000 – 10,600 nm



IR – A 870 and 930 nm non thermal
photoinactivation ( Noveon)
IR – A 532 – 595 nm thermal ablation leading to
disintegration and vaporization ( Cutera
Genesis Plus)
UV – C 254 nm pigment specific photoablation,
mutagenic interaction on genetic material



Specific intracellular chromophores in tissue
absorb radiation, providing varying degrees of
filtration of emissions
Therapeutic window refers to wavelengths
from 600 to 1200 nm
Less chromophores in this range allows for
greatest tissue penetration of emission




Thermal injury to treated and adjacent tissues
Mutagenic effects through genetic material
alteration
Ocular damage
Respiratory effects ( vapor plume from 1 gm of
ablated tissue equals roughly 5 cigarettes )
UV - C




100 – 280 nm ( 254 nm )
antibacterial and
antifungal through
genetic alteration
wound decolonization
(includes MRSA ),
treatment of
onychomycosis
Keraderm
VIS





400 – 560 nm (532 nm)
pulsed Nd:YAG laser
pigment specific tissue
ablation
Antifungal,verruca
plantaris ablation
Pinpointe, Patholase,
Cutera Genesis Plus
ND:YAG PHOTO/THERMAL
ABLATION
400 PULSES 12 -16 J/CM2, 3 HZ,
5MM SPOT SIZE, DURATION 3 MS
IR - A




560 – 1400 nm ( dual
wavelength 870 nm and
930 nm laser
specific non-thermal photo
inactivation of fungal and
bacterial pathogens, not
harmful to normal cells
wound antisepsis including
MRSA
Potentiating antibiotic
efficacy (Ciprofloxacin,
erythromycin, tetracycline )




Two separate wavelengths emitted
simultaneously
One emission is continuous, providing antiinflammatory and anti-edemic effects
The other emission is pulsed and provides
analgesic effects
Effective in tendonitis, sprains, DJD and
arthridities, effusions, bursitis, contusions,
venous ulcerations, burns, fascitis, trauma,
wound healing




5% fluorouracil cream
( 5 FU, Efudex )
Interferes with the
synthesis of DNA and
RNA
Effect most marked on
those cells that grow
more rapidly and take
up fluorouracil at a
more rapid rate
Treatment may take at
least two months





Contraindicated during
pregnancy and if breast
feeding
Especially applicable in
cases of large or many
lesions
Not to be used on
inflamed or open skin
Avoid contact with eyes
and mucous
membranes
Occlusion increases
absorption


Integument includes ulceration,
pruritis, contact dermatitis, scarring,
UV light photosensitivity
Infrequently GI, CNS, hematologic
events





Scalpel debridement every three weeks
Patient applies 5 FU cream under tape
occlusion to verruca daily, morning and
evening
Every other evening patient applies mediplast
40% salicylic acid patch over verruca, instead
of 5 FU, to be left on overnight
Removal of mediplast the next morning
provides a chemical debridement effect
Caution patient to discontinue treatment if any
blistering, ulceration or break in skin develops
Topical Treatment Options
Topaz Minimally Invasive Microdebridement
Plantar fascia bands originate at plantar tubercles, extending
proximally to blend with the achilles tendon, distally to
blend with the flexor tendons under the MTPJ’s and distally
to the toes
The greatest amount of linear
stretch through the plantar
fascia is medial plantar, with
fascitis most frequently
presenting as inflammation
of the medial fascia band
attachment to the calcaneus


Acute trauma causing an excessive stretch
through the plantar fascia ( sudden
dorsiflexion of the toes or hyperextension of
the foot on the ankle )
Chronic sub- acute trauma to the fascia
attachment at the calcaneus, often related to
biomechanical abnormality and resulting in
calcaneal hypertrophy within the plantar fascia







Longitudinal arch structure
Ankle, forefoot equinus
Body weight
Barefoot ambulation
Joint inflammatory disease
Poor or inappropriate shoe gear
Ambulatory surface (hard vs. soft, incline, ladder,
steps )





Often can contribute to development of heel
pain
Incline contributes to excessive pronation and
abduction and greater plantar fascia stretching
Increased speed adds to mechanical stresses on
the plantar fascia
Running on the treadmill creates greater heel
strike and accentuated pronation
Especially problematic if the patient has
significant equinus






Pain on the bottom of the heel, sometimes
referred to arch
Mininal pain off weight bearing
More constant pain in chronic cases
Painful when driving
Often no history of trauma, gradual onset
Worse when ambulating barefoot







Pain on palpation at the origin of the
plantar fascia from the calcaneus
Minimal pain at the body of the calcaneus,
Negative Tinel sign
No erythema or local temperature increase
No overlying skin or subcutaneous lesions
X-ray may show heel spur
MRI if suspect fascia tear
SHORT TERM TREATMENT
(RESOLUTION PHASE )




Medications
Support
Plantar fascia and
achilles tendon
stretching at least b.i.d
Limit ambulating
barefoot
LONG TERM TREATMENT
(MAINTENANCE PHASE )




Continue stretching
routine
Avoid barefoot
ambulation
May need to alter
activities to avoid
reoccurrence
Cornerstone in treatment
is orthotic control





Medications – Oral or topical NSAID, oral or
injected steroid
Support – taping, in shoe padding, Powerstep,
BFO
Stretching and massage – passive, plantar fascia
and achilles tendon, anterior or posterior night
splint, b.i.d, tennis ball, frozen juice can
Limit walking barefoot – croc, birkies, ortha heel
Rest – alter walking activities i.e.. Reduce mileage,
speed and frequency of workout, change to nonloading force workout ( bike, elliptical )




Passive stretching morning and evening and
before and after workout
Get in the habit of limiting barefoot ambulation
Alter workout routine
Appropriate shoe gear and orthotics




Shoe design
Topical options
Minimally invasive
microdebridement
Multiwave Locked System laser





Well known technology to podiatry and
pedorthics
Traditionally found in many running shoes and
orthopedic shoes
Seems to be a new trend in walking shoes
First developed by MBX
Newer siblings Easy Spirit, Sketcher ,New
Balance, Avon, Curves, Apex
MBX Rocker Shoe - Arguably the prototype of the current influx of similar style shoes
POSITIVES



More efficient gait
Unloading of heel and
forefoot
Increased shock
absorption
NEGATIVES



More heel and toe spring,
could be too drastic for
patients with balance
problems
Negative heel effect from
heel spring can be
intolerable for patients
with significant ankle
equinus
Rigid orthotics can be
uncomfortable due to
increased pressure at arch
VOLTAREN GEL




Topical version of oral
NSAID Voltaren (
diclofenac sodium )
Indicated for tendonitis,
also being used for plantar
fascitis
16 gm total per day ( 2-4
gm bid or tid )
Minimal systemic
absorption, but should not
be used concurrent with
oral NSAID
FLECTOR PATCH





Diclofenac sodium
embedded in an adhesive
patch for topical
absorption
Similar indications as
Voltaren gel
Apply q12h
Awkward in plantar
fascitis as is difficult to
maintain in position
during ambulation
Minimal systemic effect






Topaz microdebridement
Indicated for treatment of chronic plantar fascitis (
6 - 8 months of failed conservative care )
Thermographic studies show that the plantar
fascia in the chronic state of fascitis is
hypovascular, making it unresponsive to treatment
Acute state of fascitis is hypervascular
Microdebridement allows for plantar fascia
revascularization
Increased local vascular perfusion allows for
plantar fascia repair, 1 – 3 months of recovery,
minimal complications







Bipolar plasma mediated radiofrequency
coablation
68,000 cases
Minimal tissue damage, few reported
complications
Indicated for debridement of soft tissue within the
shoulder, elbow, knee, foot, ankle
Single application
Outpatient or office procedure, local anesthesia
Two different techniques, open and percutaneous






Partial tear of the plantar fascia
Acute trauma
Neurogenic disease
History of keloids
In extremely severe cases the chronic inflammation
of the plantar fascia may be too extensive for
success, requiring an open fasciotomy
Patient must be off any anti-inflammatory one
week prior to surgery and two weeks after
PERCUTANEOUS






Palpate to locate area of maximum
symptoms
Administer local anesthesia
Sterile prep
Using sterile technique mark a grid
pattern of penetration points directly
over the symptomatic area on the
plantar surface with a sterile marker
One at a time at each grid point
percutaneously produce a guide
hole using a.062 in. K-wire down to
the plantar fascia followed by the
Topaz wand
Penetration depths should vary
between 1,3,and 5 mm, 12 – 16 holes
OPEN






Location of
symptoms, anesthesia
and prep same as
percutaneous
Linear skin incision
Dissect to plantar
fascia
Produce grid pattern
with the Topaz wand
into the plantar fascia
Same penetration
depths and number of
holes,
Flush and standard
closure
GRID PATTERN FOR
PERCUTANEOUS
MICRODEBRIDEMENT
GRID PATTERN FOR OPEN
MICRODEBRIDEMENT
0.62 K-WIRE GUIDE HOLES
THROUGH THE PLANTAR
FASCIA
FOLLOW GUIDE HOLES WITH
TOPAZ MICRODEBRIDEMENT
WAND




First three weeks crutch ambulation,
immobilize with splint or cast
Week 4 – 8, passive and active range of motion
exercises and Night splint-Cam walker as
appropriate
2 -3 months, no sports or heavy lifting, routine
at home or work is okay at surgeon discretion
Post op recommendations taken from Topaz
literature






Plantar fibromatosis is a fibrotic tissue disorder of
the plantar aponeurosis characterized by excess
collagen formation and fibrosis
Fibromatosis may be palpable as single or multiple
firm nodules, or can be nonpalpable with
generalized fascia thickening
Sometimes bilateral
MRI confirms diagnosis and rules out sarcoma
Traditional treatment includes unloading,
injections or surgery
A new option in treatment is Transdermal
Verapamil Gel




Ten times more often in males
Caucasians of northern European descent tend
to be more affected
25% in middle age to elderly
Increased incidence in diabetes mellitus and
seizure disorders





Trauma to the plantar aponeurosis causing
overproduction of collagen/fibrotic tissue
Reduction in normal tissue elasticity and local
prominence contributes to pain on ambulation
Genetic predisposition to fibromatosis and
other fibrotic tissue disorders
May have concurrent Dupuytren’s contracture
Beta blocking agents, antiseizure medications,
glucosamine/chondroitin, large doses of
vitamin C can promote the production of
excess collagen






Local steroid injections usually fail as the density of the
fibromatosis does not allow adequate medication
dispersion
Multiple injections may worsen the condition due to
trauma
Nonpalpable fibrosis is indiscernible, thereby making
injection therapy ineffective
Surgical removal has a 57% rate of reoccurrence, but
may need consideration in cases of larger lesion
Orthotics are used to manage pain symptoms but will
not resolve the problem
Transdermal Verapamil Gel offers resolution with less
risk of complications




Verapamil is a calcium channel blocker
The flow of calcium into fibroblasts through
calcium channels in the cell membrane is
required for the production of excess collagen
that forms the plantar fibroma
By blocking the calcium channels Verapamil
slows or stops collagen production in fibroma
growth
Calcium channel blockage also causes
increased fibroblast collagenase production
which allows for fibroma collagen reduction




Apply to the entire plantar aponeurosis,
treating both palpable and non-palpable
fibromatosis
Fibrosis reduction works cumulatively,
adequate concentration levels need to be built
up and maintained for sustained collagenase
activity
No systemic or localized adverse effects have
been reported
Standard treatment time is 6 – 12 months




Beta blockers used to treat hypertension and
cardiac arrythmia can cause tissue fibrosis, may
reduce effectiveness of Verapamil
Oral Verapamil can interfere with the metabolism
and elimination of statin drugs,
digoxin/cyclosporin, with risk of toxic levels –
Transdermal Verapamil has minimal systemic
absorption, but patient should be advised about
this possible adverse effect
Nicotene impedes the skin’s ability to absorb
topical medications
Do not apply under occlusion






Wash and dry bottom of affected foot
Apply two 0.5 ml doses twice per day using the
dosimeter included with the medication
Each application is to the entire bottom of the foot
Massage the medication into the skin for
approximately 1 – 2 minutes, wait 5 minutes, then
continue to rub into the skin for another 1 – 2
minutes
Repeat the application process
The application procedures should be repeated
morning and evening every day
In Severe Cases of Plantar
Fibromatosis, Surgical Intervention
May Be Necessary………..
Surgery in Plantar Fibromatosis
Dissecting the Lesion
Distal fascia band






Onychomycosis Keraderm, Pinpointe , Patholase,
and Noveon laser systems
Wound care/antisepsis Patholase, Pinpointe, and
Noveon laser systems
Antibiotic potentiation Noveon laser systems
Plantar fascitis MLS laser systems, Topaz
Arthrocare Sports Medicine, MBX shoes,Voltaren
gel, Flector Patch King Pharmaceuticals
Plantar fibromatosis Pd labs transdermal
verapamil
Verruca plantaris Efudex ICN Pharmaceuticals,
Pinpointe, Patholase